ZeroStack Corp., formerly known as Flora Growth Corp., reported a revenue of $7.3 million for the first quarter of 2026, marking a 6% increase from $6.9 million in the same period of 2025. The revenue was primarily driven by the company's pharmaceutical distribution subsidiary, Phatebo, which generated $4.5 million, down from $6.9 million year-over-year. The company also began staking its 0G Tokens in January 2026, earning approximately $2.8 million in staking rewards during the quarter. Despite the increase in revenue, ZeroStack recorded a net loss of $36.7 million, significantly higher than the $0.8 million loss reported in the prior year, largely due to a $60.7 million loss from changes in the fair value of digital assets.

The company's financial position showed a substantial decline in total assets, which decreased to $45.2 million as of March 31, 2026, down from $130.2 million at the end of 2025. This decline was attributed to a significant reduction in digital assets, which fell from $72 million to $38.4 million, primarily due to losses in the value of 0G Tokens. The company's cash reserves also decreased to $2.3 million from $5.6 million, raising concerns about liquidity and the ability to meet operational needs.

Strategically, ZeroStack has undergone significant changes, including the sale of its legacy hemp and cannabis business in September 2025, allowing the company to focus on its digital asset treasury strategy. The company is in the process of acquiring Texas Blocker Corp., which will become a wholly-owned subsidiary upon completion of a share exchange agreement expected around July 14, 2026. This acquisition is part of ZeroStack's broader strategy to enhance its position in the decentralized AI infrastructure market.

Operationally, the company reported a gross profit of $3.1 million for the quarter, reflecting a gross margin of 43%, a notable increase from 8% in the previous year. This improvement is attributed to the commencement of staking activities. However, total operating expenses surged to $65.8 million, driven by the aforementioned losses in digital asset valuations and increased share-based compensation expenses. The company’s employee headcount and customer engagement metrics were not disclosed in the filing.

Looking ahead, ZeroStack's management expressed optimism about its liquidity position, bolstered by recent equity offerings and the anticipated benefits from its digital asset strategy. The company believes that its existing cash and staking rewards will be sufficient to meet its working capital requirements for at least the next year. However, the ongoing volatility in digital asset markets and the company's reliance on these assets for revenue generation present significant risks that could impact future performance.

About Flora Growth Corp.

Flora Growth Corp. is a multinational cannabis company specializing in the manufacturing and distribution of consumer packaged goods, medicinal cannabis, and pharmaceutical products. Its core segments include wellness, nutraceuticals, accessories, and medical cannabis, with key brands like JustCBD and Vessel. The company leverages a diversified strategy, global supply chain expertise, and regulatory licenses to serve markets in North America, Europe, and beyond, focusing on quality, innovation, and strategic acquisitions.

This description was generated via AI from an annual report. Updated 9 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.